Skip to main content
×
Home
    • Aa
    • Aa

Polypharmacy with antidepressants in children and adolescents

  • Covadonga M. Díaz-Caneja (a1), Ana Espliego (a1), Mara Parellada (a1), Celso Arango (a1) and Carmen Moreno (a1)...
Abstract
Abstract

The aim of this study was to review current epidemiological data on the use of antidepressants in co-prescription with other psychotropic drugs in children and adolescents, as well as available efficacy and safety information. A Medline search from inception until February 2012 was performed to identify epidemiological and clinical studies, reviews and reports containing potentially relevant information on polypharmacy with antidepressants in young people. There has been an increase in polypharmacy in children and adolescents involving antidepressants in recent years. Antidepressants have become one of the drug classes most frequently prescribed in combination and are commonly co-prescribed with stimulants and antipsychotics. Most information regarding efficacy and safety of polypharmacy patterns was provided by case series and open-label studies. Efficacy studies gave some support for the use of a combination of antidepressants and antipsychotics in the management of refractory obsessive–compulsive disorder and some residual symptoms in major depressive disorder. Even less empirical support was found for a combination of stimulants and antidepressants in co-morbid attention deficit hyperactivity disorder and mood or anxiety disorders. Adverse events were similar to those found with individual medication groups, with severe adverse events mostly reported by individual case reports. The use of polypharmacy with antidepressants has become a regular practice in clinical settings. Although there is still little efficacy and safety information, preliminary evidence points to the potential clinical usefulness of some polypharmacy patterns. Further research on patients with co-morbidities or more severe conditions is needed, in order to improve knowledge of this issue.

Copyright
Corresponding author
Address for correspondence: C. Moreno, MD, PhD, Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM., Instituto de Investigación Sanitaria Gregorio Marañón, C/ Ibiza 43, 28009 Madrid, Spain. Tel.: 0034 91426 5005Fax: 0034 91426 5004Email: cmoreno@hggm
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

H Abikoff , J McGough , B Vitiello , J McCracken , (2005) Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. J Am Acad Child Adolesc Psychiatry 44:418427.

G Aldurra , JW Crayton (2001) Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report. J Clin Psychopharmacol 21:343344.

American Academy of Children and Adolescent Psychiatry (1998) Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 37:27S45S.

American Academy of Children and Adolescent Psychiatry (2009) Practice parameter on the use of psychotropic medication in children and adolescents. J Am Acad Child Adolesc Psychiatry 48:961973.

E Anagnostou , K Esposito , L Soorya , W Chaplin , (2006) Divalproex vs. placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. J Clin Psychopharmacol 26:444446.

SW Andersen , DB Clemow , SA Corya (2005). Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder. J Clin Psychiatry 66:14681476.

DJ Belle , CS Ernest , JM Sauer , BP Smith , (2002). Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics. J Clin Pharmacol 42:12191227.

VS Bhatara , M Feil , K Hoagwood , B Vitiello , (2004). National trends in concomitant psychotropic medication with stimulants in pediatric visits: practice vs. knowledge. J Attent Disord 7:217226.

J Biederman , E Mick , TJ Spencer , TE Wilens , (2000). Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 10:185192.

B Birmaher , D Brent , W Bernet , O Bukstein , (2007). Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 46:15031526.

JC Blader , GA Carlson (2007). Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996–2004. Biol Psychiatry 62:107114.

MH Bloch , A Landeros-Weisenberger , B Kelmendi , V Coric , (2006). A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11:622632.

JA Bridge , S Iyengar , CB Salary , RP Barbe , (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. J Am Med Assoc 297:16831696.

CL Budman , M Sherling , RD Bruun (1995). Combined pharmacotherapy risk. J Am Acad Child Adolesc Psychiatry 34:263264.

MS Burke , A Josephson , A Lightsey (1995). Combined methylphenidate and imipramine complication. J Am Acad Child Adolesc Psychiatry 34:403404.

R Bussing , GM Levin (1993). Methamphetamine and fluoxetine treatment of a child with attention-deficit hyperactivity disorder and obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 3:5358.

PH Caldwell , SB Murphy , PN Butow , JC Craig (2004). Clinical trials in children. Lancet 364:803811.

AH Cheung , GJ Emslie , TL Mayes (2005). Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry 46:735754.

JS Comer , M Olfson , R Mojtabai (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007. J Am Acad Child Adolesc Psychiatry 49:10011010.

DF Connor , KR Ozbayrak , KA Kusiak , AB Caponi , (1997). Combined pharmacotherapy in children and adolescents in a residential treatment center. J Am Acad Child Adolesc Psychiatry 36:248254.

CU Correll , HE Carlson (2006). Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 45:771791.

M Coskun , S Zoroglu (2008). Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination. J Clin Psychopharmacol 28:723725.

EJ Costello , S Mustillo , A Erkanli , G Keeler , (2003). Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60:837844.

NA Crossley , M Bauer (2007). Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry 68:935940.

AR Curtis , RW Richards (2007). The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine. Ann Clin Psychiatry 19:199200.

WB Daviss , P Bentivoglio , R Racusin , KM Brown , (2001). Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry 40:307314.

AJ Dean , BM McDermott , RT Marshall (2006). Psychotropic medication utilization in a child and adolescent mental health service. J Child Adolesc Psychopharmacol 16:273285.

C DeBattista , J Hawkins (2009). Utility of atypical antipsychotics in the treatment of resistant unipolar depression. CNS Drugs 23:369377.

M de Wit , FJ Snoek (2011). Depressive symptoms and unmet psychological needs of Dutch youth with type 1 diabetes: results of a web-survey. Pediatr Diabetes 12:172176.

S dosReis , JM Zito , DJ Safer , JF Gardner , (2005). Multiple psychotropic medication use for youths: a two-state comparison. J Child Adolesc Psychopharmacol 15:6877.

B Dubicka , S Hadley , C Roberts (2006). Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry 189:393398.

FF Duffy , WE Narrow , DS Rae , JC West , (2005). Concomitant pharmacotherapy among youths treated in routine psychiatric practice. J Child Adolesc Psychopharmacol 15:1225.

HS Duggal , PC Pathak , CC Coleman (2003). Treating selective serotonin reuptake inhibitor-induced behavioral activation with valproate. J Child Adolesc Psychopharmacol 13:113114.

ES Ercan , H Copkunol , S Cykoethlu , A Varan (2003). Olanzapine treatment of an adolescent girl with anorexia nervosa. Hum Psychopharmacol 18:401403.

BH Esbjorn , M Hoeyer , J Dyrborg , I Leth , (2010). Prevalence and co-morbidity among anxiety disorders in a national cohort of psychiatrically referred children and adolescents. J Anxiety Disord 24:866872.

CA Essau (2008). Comorbidity of depressive disorders among adolescents in community and clinical settings. Psychiatry Res 158:3542.

A Faber , LT de Jong-van den Berg , PB van den Berg , H Tobi (2005). Psychotropic co-medication among stimulant-treated children in The Netherlands. J Child Adolesc Psychopharmacol 15:3843.

SV Faraone , J Biederman , CP Morley , TJ Spencer (2008). Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry 47:9941009.

DJ Feeney , WM Klykylo (1997). Medication-induced seizures. J Am Acad Child Adolesc Psychiatry 36:10181019.

JM Fegert , M Kolch , JM Zito , G Glaeske , (2006). Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16:197206.

Y Figueroa , DR Rosenberg , B Birmaher , MS Keshavan (1998). Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol 8:6167.

RL Findling (1996). Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol 6:165175.

RL Findling , J Lingler , BM Rowles , NK McNamara , (2008). A pilot pharmacotherapy trial for depressed youths at high genetic risk for bipolarity. J Child Adolesc Psychopharmacol 18:615621.

KD Fitzgerald , CM Stewart , V Tawile , DR Rosenberg (1999). Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. J Child Adolesc Psychopharmacol 9:115123.

CA Fontanella , JA Bridge , JV Campo (2009). Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients. Ann Pharmacother 43:19391947.

D Fraguas , CU Correll , J Merchan-Naranjo , M Rapado-Castro , (2011). Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons. Eur Neuropsychopharmacol 21:621645.

D Fraguas , J Merchan-Naranjo , C Arango (2010). Differential characteristics of the efficacy and tolerability of second-generation antipsychotics in the treatment of psychotic disorders in children and adolescents. Rev Psiquiat Salud Ment 3:152167.

GD Gammon , TE Brown (1993). Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 3:110.

B Geller , R Tillman , K Bolhofner , B Zimerman (2010). Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up. Bipolar Disord 12:164171.

D Geller , C Donnelly , F Lopez , R Rubin , (2007). Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 46:11191127.

DA Geller , J Biederman , ED Reed , T Spencer , (1995). Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 34:3644.

AK George , AR Kunwar , A Awasthi (2005). Acute myocardial infarction in a young male on methylphenidate, bupropion, and erythromycin. J Child Adolesc Psychopharmacol 15:693695.

N Ghaziuddin , A Iqbal , S Khetarpal (2001). Myoclonus during prolonged treatment with sertraline in an adolescent patient. J Child Adolesc Psychopharmacol 11:199202.

RD Gibbons , K Hur , DK Bhaumik , JJ Mann (2006). The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry 163:18981904.

CR Good (2006). Adjunctive quetiapine targets self-harm behaviors in adolescent females with major depressive disorder. J Child Adolesc Psychopharmacol 16:235236.

J Graham , D Coghill (2008). Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. CNS Drugs 22:213237.

TA Hammad , TP Laughren , JA Racoosin (2006). Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol 26:203207.

S Hawkridge , DJ Stein , C Bouwer (1996). Combined pharmacotherapy for TS and OCD. J Am Acad Child Adolesc Psychiatry 35:703704.

CW Hughes , GJ Emslie , ML Crismon , K Posner , (2007). Texas children's medication algorithm project: update from texas consensus conference panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry 46:667686.

EM Hunkeler , B Fireman , J Lee , R Diamond , (2005). Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994–2003. J Child Adolesc Psychopharmacol 15:2637.

EA Kastelic , MJ Labellarte , MA Riddle (2000). Selective serotonin reuptake inhibitors for children and adolescents. Curr Psychiatry Rep 2:117123.

PC Kendall , SN Compton , JT Walkup , B Birmaher , (2010). Clinical characteristics of anxiety disordered youth. J Anxiety Disord 24:360365.

B Kennard , S Silva , B Vitiello , J Curry , (2006). Remission and residual symptoms after short-term treatment in the treatment of adolescents with depression study (TADS). J Am Acad Child and Adolesc Psychiatry 45:14041411.

M Koelch , A Prestel , H Singer , F Keller , (2009). Psychotropic medication in children and adolescents in Germany: prevalence, indications, and psychopathological patterns. J Child Adolesc Psychopharmacol 19:756770.

RA Kowatch , M Fristad , B Birmaher , KD Wagner , (2005). Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:213235.

CJ Kratochvil , JH Newcorn , LE Arnold , D Duesenberg , (2005). Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry 44:915924.

BP Kurtz , AN Abrams (2010). Psychiatric aspects of pediatric cancer. Child Adolesc Psychiatric Clin N Am 19:401421.

K Larson , SA Russ , RS Kahn , N Halfon (2011). Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 127:462470.

E Lee , AR Teschemaker , R Johann-Liang , G Bazemore , (2012). Off-label prescribing patterns of antidepressants in children and adolescents. Pharmacoepidemiol Drug Saf 21:137144.

AM Libby , HD Orton , RJ Valuck (2009). Persisting decline in depression treatment after FDA warnings. Arch Gen Psychiatry 66:633639.

M Lopez-Larson , JA Frazier (2006). Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders. Harv Rev Psychiatry 14:285304.

J Ma , KV Lee , RS Stafford (2005). Depression treatment during outpatient visits by U.S. children and adolescents. J Adolesc Health 37:434442.

RS McIntyre , JM Jerrell (2009). Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study. J Clin Psychiatry 70:240246.

S Mahapatra , JL Belgrad , MA Adeoye (2011). Psychotropic drug-related eosinophilia with systemic symptoms after acute caffeine ingestion. Pediatrics 127:e235e238.

J Mancini , X Thirion , A Masut , C Saillard , (2006). Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. Pharmacoepidemiol Drug Saf 15:494503.

A Martin , T Van Hoof , D Stubbe , T Sherwin , (2003). Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatr Serv 54:7277.

G Masi , S Millepiedi , G Perugi , C Pfanner , (2009). Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study. CNS Drugs 23:241252.

G Masi , G Perugi , S Millepiedi , C Toni , (2007). Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications. J Child Adolesc Psychopharmacol 17:475486.

G Masi , C Pfanner , S Millepiedi , S Berloffa (2010). Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder. J Clin Psychopharmacol 30:688693.

KR Merikangas , JP He , M Burstein , SA Swanson , (2010). Lifetime prevalence of mental disorders in U.S. adolescents: results from the national comorbidity survey replication–adolescent supplement (NCS-A). J Am Acad Child Adolesc Psychiatry 49:980989.

C Moreno , G Laje , C Blanco , H Jiang , (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 64:10321039.

C Moreno , J Merchan-Naranjo , M Alvarez , I Baeza , (2010). Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses. Bipolar Disord 12:172184.

C Moreno , AM Roche , LL Greenhill (2006). Pharmacotherapy of child and adolescent depression. Child Adolesc Psychiatric Clin N Am 15:977998.

S Nagar , JT Sherer , H Chen , RR Aparasu (2010). Extent of functional impairment in children and adolescents with depression. Curr Med Res Opin 26:20572064.

CB Nemeroff , A Kalali , MB Keller , DS Charney , (2007). Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 64:466472.

M Olfson , D Shaffer , SC Marcus , T Greenberg (2003a). Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60:978982.

M Olfson , MJ Gameroff , SC Marcus , PS Jensen (2003b). National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry 160:10711077.

M Olfson , SC Marcus , MM Weissman , PS Jensen (2002). National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 41:514521.

O Oner , P Oner (2008). Psychopharmacology of pediatric obsessive-compulsive disorder: three case reports. J Psychopharmacol 22:809811.

T Owley , S Owley , B Leventhal , EH Cook Jr. (2002). Case series: Adderall augmentation of serotonin reuptake inhibitors in childhood-onset obsessive compulsive disorder. J Child Adolesc Psychopharmacol 12:165171.

O Ozcan , MA Selimoglu (2009). Self-injury behavior in an adolescent with Wilson's disease. Eur Child Adolesc Psychiatry 18:761762.

D Padla (2001). Quetiapine resolves psychotic depression in an adolescent boy. J Child Adolesc Psychopharmacol 11:207208.

YM Park , YK Jung (2010). Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression. Prog Neuropsychopharmacol Biol Psychiatry 34:719720.

S Pathak , A Danielyan , RA Kowatch (2004). Successful treatment of trichotillomania with olanzapine augmentation in an adolescent. J Child Adolesc Psychopharmacol 14:153154.

S Pathak , ES Johns , RA Kowatch (2005). Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series. J Child Adolesc Psychopharmacol 15:696702.

SR Pliszka , ML Crismon , CW Hughes , CK Corners , (2006). The Texas children's medication algorithm project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:642657.

J Puig-Antich , E Lukens , M Davies , D Goetz , (1985). Psychosocial functioning in prepubertal major depressive disorders. I. Interpersonal relationships during the depressive episode. Arch Gen Psychiatry 42:500507.

R Raghavan , JC McMillen (2008). Use of multiple psychotropic medications among adolescents aging out of foster care. Psychiatr Serv 59:10521055.

E Reed , A Vance , E Luk , K Nunn (2004). Single and combined psychotropic medication use in a child and adolescent mental health service. Aust N Z J Psychiatry 38:204211.

H Rittmannsberger (2002). The use of drug monotherapy in psychiatric inpatient treatment. Prog Neuropsychopharmacol Biol Psychiatry 26:547551.

LM Robison , TL Skaer , DA Sclar , RS Galin (2002). Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants. CNS Drugs 16:129137.

AJ Rush , MH Trivedi , JW Stewart , AA Nierenberg , (2011). Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. Am J Psychiatry 168:689701.

JL Rushton , JT Whitmire (2001). Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 155:560565.

PS Russell , C George , P Mammen (2006). Predictive factors for polypharmacy among child and adolescent psychiatry inpatients. Clin Pract Epidemiol Ment Health 2:25.

ND Ryan , V Meyer , S Dachille , D Mazzie , (1988). Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry 27:371376.

DJ Safer , JM Zito (2006). Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children vs. adolescents. J Child Adolesc Psychopharmacol 16:159169.

DJ Safer , JM Zito , S DosReis (2003). Concomitant psychotropic medication for youths. Am J Psychiatry 160:438449.

FR Sallee , CL DeVane , RE Ferrell (2000). Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency. J Child Adolesc Psychopharmacol 10:2734.

M Schertz , T Steinberg (2008). Seizures induced by the combination treatment of methylphenidate and sertraline. J Child Adolesc Psychopharmacol 18:301303.

E Schirm , H Tobi , JM Zito , LT de Jong-van den Berg (2001). Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:E25.

TL Skaer , DA Sclar , LM Robison (2009). Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: an assessment of accordance with treatment recommendations from the American academy of child and adolescent psychiatry. Clin Ther 31:14781487.

SA Smathers , JG Wilson , MA Nigro (2003). Topiramate effectiveness in Prader–Willi syndrome. Pediatr Neurol 28:130133.

A Sourander (2004). Combined psychopharmacological treatment among child and adolescent inpatients in Finland. Eur Child Adolesc Psychiatry 13:179184.

RK Srivastava , S Sharma , N Tiwari , B Saluja (2005). Olanzapine augmentation of fluoxetine in trichotillomania: two cases. Aust N Z J Psychiatry 39:112113.

JA Staller , MJ Wade , M Baker (2005). Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York. J Child Adolesc Psychopharmacol 15:5761.

EA Storch , LJ Merlo , MJ Larson , WE Marien , (2008). Clinical features associated with treatment-resistant pediatric obsessive-compulsive disorder. Compr Psychiatry 49:3542.

M Strober , R Freeman , J Rigali , S Schmidt , (1992). The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine. J Am Acad Child Adolesc Psychiatry 31:1620.

PH Thomsen (2004). Risperidone augmentation in the treatment of severe adolescent OCD in SSRI-refractory cases: a case-series. Ann Clin Psychiatry 16:201207.

PH Thomsen , HU Mikkelsen (1999). The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases. Eur Child Adolesc Psychiatry 8:143148.

KJ Took , BJ Buck (1996). Enuresis with combined risperidone and SSRI use. J Am Acad Child Adolesc Psychiatry 35:840841.

T Usala , A Clavenna , A Zuddas , M Bonati (2008). Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur Neuropsychopharmacol 18:6273.

E Vieta , J Locklear , O Gunther , M Ekman , (2010). Treatment options for bipolar depression: a systematic review of randomized, controlled trials. J Clin Psychopharmacol 30:579590.

B Vitiello (2008). An international perspective on pediatric psychopharmacology. Int Rev Psychiatry 20:121126.

KD Wagner , P Ambrosini , M Rynn , C Wohlberg , (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. J Am Med Assoc 290:10331041.

KD Wagner , AS Robb , RL Findling , J Jin , (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry 161:10791083.

G Walter , B Lyndon , R Kubb (1998). Lithium augmentation of venlafaxine in adolescent major depression. Aust N Z J Psychiatry 32:457459.

AM Wehr , LB Namerow (2001). Citalopram for OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 40:740741.

N Weintrob , D Cohen , Y Klipper-Aurbach , Z Zadik , (2002). Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 156:696701.

J Wijkstra , J Lijmer , FJ Balk , JR Geddes , (2006). Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis. Br J Psychiatry 188:410415.

TE Wilens , J Biederman , A Kwon , R Chase , (2004). A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adolesc Psychopharmacol 13:143152.

JM Zito , DJ Safer , LT de Jong-van den Berg , K Janhsen , (2008). A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2:26.

JM Zito , DJ Safer , S DosReis , JF Gardner , (2002). Rising prevalence of antidepressants among US youths. Pediatrics 109:721727.

JM Zito , H Tobi , LT de Jong-van den Berg , JM Fegert , (2006). Antidepressant prevalence for youths: a multi-national comparison. Pharmacoepidemiol Drug Saf 15:793798.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The International Journal of Neuropsychopharmacology
  • ISSN: 1461-1457
  • EISSN: 1469-5111
  • URL: /core/journals/the-international-journal-of-neuropsychopharmacology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: